1. A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy. Issue 5 (October 2016) Authors: Kottschade, Lisa; Brys, Adam; Peikert, Tobias; Ryder, Mabel; Raffals, Laura; Brewer, Jerry; Mosca, Paul; Markovic, Svetomir Journal: Melanoma research Issue: Volume 26:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Categorisation of patients based on immune profiles: a new approach to identifying candidates for response to checkpoint inhibitors. Issue 4 (29th April 2021) Authors: Bornschlegl, Svetlana; Gustafson, Michael P; Delivanis, Danae A; Ryder, Mabel; Liu, Minetta C; Vasmatzis, George; Hallemeier, Chris L; Park, Sean S; Roberts, Lewis R; Parney, Ian F; Jelinek, Diane F; Dietz, Allan B Journal: Clinical & translational immunology Issue: Volume 10:Issue 4(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma. Issue 2 (30th July 2020) Authors: Bedrose, Sara; Miller, Kevin Charles; Altameemi, Lina; Ali, Mohamed S; Nassar, Sameh; Garg, Naveen; Daher, Marilyne; Eaton, Keith D; Yorio, Jeffrey Thomas; Daniel, Davey B; Campbell, Matthew; Bible, Keith C; Ryder, Mabel; Chintakuntlawar, Ashish V; Amir Habra, Mouhammed Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗